(VIANEWS) – Ritchie Bros. Auctioneers Incorporated (RBA), CIRCOR International (CIR), Boston Scientific (BSX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ritchie Bros. Auctioneers Incorporated (RBA)
136% sales growth and 3.45% return on equity
Ritchie Bros. Auctioneers Incorporated, an asset management and disposition company, sells industrial equipment and other durable assets through its unreserved auctions, online marketplaces, listing services, and private brokerage services. It sells a range of used and unused commercial assets, including earthmoving equipment, truck tractors and trailers, government surplus, oil and gas equipment, and other industrial assets, as well as construction and heavy machinery. The company also offers live auction events with online bidding. It sells used equipment to its customers through live unreserved auctions at 40 auction sites worldwide. The company serves construction, transportation, agriculture, energy, oil and gas, mining, and forestry sectors. It operates in the United States, Canada, Australia, the United Arab Emirates, the Netherlands, Europe, the Middle East, Asia, and internationally. Ritchie Bros. Auctioneers Incorporated was founded in 1958 and is headquartered in Burnaby, Canada.
Earnings Per Share
As for profitability, Ritchie Bros. Auctioneers Incorporated has a trailing twelve months EPS of $0.98.
PE Ratio
Ritchie Bros. Auctioneers Incorporated has a trailing twelve months price to earnings ratio of 65.8. Meaning, the purchaser of the share is investing $65.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.45%.
Volume
Today’s last reported volume for Ritchie Bros. Auctioneers Incorporated is 801012 which is 51.05% below its average volume of 1636650.
Yearly Top and Bottom Value
Ritchie Bros. Auctioneers Incorporated’s stock is valued at $64.48 at 16:22 EST, way below its 52-week high of $72.73 and way higher than its 52-week low of $48.72.
Sales Growth
Ritchie Bros. Auctioneers Incorporated’s sales growth is 118.9% for the current quarter and 136% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 30.1%, now sitting on 1.85B for the twelve trailing months.
2. CIRCOR International (CIR)
12.7% sales growth and 29.8% return on equity
CIRCOR International, Inc. designs, manufactures, and distributes flow and motion control products. The company has a product portfolio of brands serving its customers' demanding applications. It operates through two segments, Aerospace & Defense and Industrial. The Aerospace & Defense segment manufactures and markets control valves, pumps, regulators, fluid controls, actuation systems, pneumatic valves and controls, electro-mechanical controls, motors, and other flow control products and systems. Its products and services are used in the military and defense, commercial aerospace, business and general aviation, and general industrial markets, as well as serves aircraft manufacturers and tier 1 suppliers. This segment offers its products under the CIRCOR Aerospace, Aerodyne Controls, CIRCOR Bodet, CIRCOR Industria, CIRCOR Motors, Hale Hamilton, Leslie Controls, Portland Valve, and Warren Pumps brands. The Industrial segment provides 3 and 2 screw pumps, progressing cavity pumps, specialty centrifugal pumps, and gear metering pumps; automatic recirculation valves; general service control valves; and pipeline pigs and closures for the end-users and original equipment manufacturers, as well as engineering, procurement, and construction companies. This segment offers its products under the Allweiler, Houttuin, IMO Pump, IMO AB, Leslie Controls, RG Lawrence, RTK, Schroedahl, Tushaco, and Zenith brands. The company has operations in Europe, the Middle East, Africa, North America, and internationally. The company markets its solutions directly and through various sales partners to approximately 14,000 customers in approximately 100 countries. CIRCOR International, Inc. was incorporated in 1999 and is headquartered in Burlington, Massachusetts.
Earnings Per Share
As for profitability, CIRCOR International has a trailing twelve months EPS of $1.98.
PE Ratio
CIRCOR International has a trailing twelve months price to earnings ratio of 28.08. Meaning, the purchaser of the share is investing $28.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.8%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 9.4% and a drop 17.4% for the next.
Moving Average
CIRCOR International’s value is way higher than its 50-day moving average of $46.53 and way higher than its 200-day moving average of $30.96.
Volume
Today’s last reported volume for CIRCOR International is 142554 which is 68.36% below its average volume of 450568.
Earnings Before Interest, Taxes, Depreciation, and Amortization
CIRCOR International’s EBITDA is 36.58.
3. Boston Scientific (BSX)
11.7% sales growth and 5.18% return on equity
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Earnings Per Share
As for profitability, Boston Scientific has a trailing twelve months EPS of $0.59.
PE Ratio
Boston Scientific has a trailing twelve months price to earnings ratio of 86.13. Meaning, the purchaser of the share is investing $86.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.18%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Boston Scientific’s EBITDA is 6.2.
Yearly Top and Bottom Value
Boston Scientific’s stock is valued at $50.81 at 16:22 EST, under its 52-week high of $54.75 and way above its 52-week low of $37.74.
4. McCormick & Company (MKC)
8.6% sales growth and 14.62% return on equity
McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry. It operates in two segments, Consumer and Flavor Solutions. The Consumer segment offers spices, herbs, and seasonings, as well as condiments and sauces, and desserts. This segment markets its products under the McCormick, French's, Frank's RedHot, Lawry's, Cholula Hot Sauce, Gourmet Garden, Club House, and OLD BAY brands in the Americas; Ducros, Schwartz, Kamis, and LA Drogheria, and Vahiné brands in Europe, the Middle East, and Africa; McCormick and DaQiao brands in China; and McCormick, Aeroplane, and Gourmet Garden brands in Australia, as well as markets regional and ethnic brands, such as Zatarain's, Stubb's, Thai Kitchen, and Simply Asia. It also supplies its products under the private labels. This segment serves retailers comprising grocery, mass merchandise, warehouse clubs, discount and drug stores, and e-commerce retailers directly and indirectly through distributors and wholesale foodservice suppliers. The Flavor Solutions segment offers seasoning blends, spices and herbs, condiments, coating systems, and compound flavors to multinational food manufacturers and foodservice customers. It serves foodservice customers directly and indirectly through distributors. McCormick & Company, Incorporated was founded in 1889 and is headquartered in Hunt Valley, Maryland.
Earnings Per Share
As for profitability, McCormick & Company has a trailing twelve months EPS of $2.59.
PE Ratio
McCormick & Company has a trailing twelve months price to earnings ratio of 33.85. Meaning, the purchaser of the share is investing $33.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.62%.
Moving Average
McCormick & Company’s worth is below its 50-day moving average of $88.66 and above its 200-day moving average of $82.46.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8%, now sitting on 6.52B for the twelve trailing months.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jul 6, 2023, the estimated forward annual dividend rate is 1.56 and the estimated forward annual dividend yield is 1.74%.
Sales Growth
McCormick & Company’s sales growth is 5.6% for the current quarter and 8.6% for the next.
